Method for in vivo identification of intracellular epitopes
CA 2426744 A1 · Owner: S.I.S.S.A. Scuola Internazionale Superiore Di Studi Avanzati · Inventors: Cattaneo, Antonino; Visintin, Michela
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
A method is described for the in vivo identification of epitopes of an intracellular antigen comprising the steps of: a) co-transforming of cells by a first vector including the nucleotide sequence encoding for the region of an antibody able to recognise and bind the intracellular antigen and by a second vector comprising the nucleotide sequence encoding for a peptide; b) growing co-transformed cells in such an environment that only cells wherein the antibody region and peptide recognise and interact each other are able to replicate and/or be recognised because: the antibody region able to recognise and bind the intracellular antigen is associated with a first molecule; the peptide …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed October 22, 2001. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended October 22, 2021.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by October 22, 2023.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.